These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21424451)

  • 21. Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.
    Mazor Y; Van Blarcom T; Carroll S; Georgiou G
    FEBS J; 2010 May; 277(10):2291-303. PubMed ID: 20423457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model.
    Albac S; Medina M; Labrousse D; Hayez D; Bonnot D; Anzala N; Laurent F; Ferry T; Dublanchet A; Chavanet P; Fevre C; Croisier D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-targeted gene delivery using multivalent phagemid particles.
    Larocca D; Jensen-Pergakes K; Burg MA; Baird A
    Mol Ther; 2001 Apr; 3(4):476-84. PubMed ID: 11319907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.
    Ju Z; Sun W
    Drug Deliv; 2017 Nov; 24(1):1898-1908. PubMed ID: 29191048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of phages to prevent MRSA infections.
    Mann NH
    Res Microbiol; 2008 Jun; 159(5):400-5. PubMed ID: 18541414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the risks of Staphylococcus aureus infections and their control by bacteriophages and bacteriophage-encoded products.
    Rai A; Khairnar K
    Braz J Microbiol; 2021 Dec; 52(4):2031-2042. PubMed ID: 34251609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells.
    Kassner PD; Burg MA; Baird A; Larocca D
    Biochem Biophys Res Commun; 1999 Nov; 264(3):921-8. PubMed ID: 10544031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections.
    O'Flaherty S; Ross RP; Flynn J; Meaney WJ; Fitzgerald GF; Coffey A
    Lett Appl Microbiol; 2005; 41(6):482-6. PubMed ID: 16305674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
    Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
    Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.
    Parisien A; Allain B; Zhang J; Mandeville R; Lan CQ
    J Appl Microbiol; 2008 Jan; 104(1):1-13. PubMed ID: 18171378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.
    Cobb LH; Park J; Swanson EA; Beard MC; McCabe EM; Rourke AS; Seo KS; Olivier AK; Priddy LB
    PLoS One; 2019; 14(11):e0220421. PubMed ID: 31756187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection.
    Pincus NB; Reckhow JD; Saleem D; Jammeh ML; Datta SK; Myles IA
    PLoS One; 2015; 10(4):e0124280. PubMed ID: 25909449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F; Tanaka Y; Minari Y; Tokui N
    J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies.
    Kaźmierczak Z; Majewska J; Miernikiewicz P; Międzybrodzki R; Nowak S; Harhala M; Lecion D; Kęska W; Owczarek B; Ciekot J; Drab M; Kędzierski P; Mazurkiewicz-Kania M; Górski A; Dąbrowska K
    Front Immunol; 2021; 12():639570. PubMed ID: 34194425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.
    Sunderland KS; Yang M; Mao C
    Angew Chem Int Ed Engl; 2017 Feb; 56(8):1964-1992. PubMed ID: 27491926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination utility of phages GH15 and K against Staphylococcus aureus].
    Liu X; Gu J; Han W; Li Y; Han D; Zhang Q; Lu R; Song J; Feng X; Lei L
    Wei Sheng Wu Xue Bao; 2013 May; 53(5):498-506. PubMed ID: 23957155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.